Skip to content

NOboRi biolimus A9-Eluting stent for right Coronary OstIum Lesion (NO RECOIL) registry

NOboRi biolimus A9-Eluting stent for right Coronary OstIum Lesion (NO RECOIL) registry - NO RECOIL registry

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000008166
Enrollment
120
Registered
2012-06-20
Start date
2011-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angina pectoris

Interventions

NOBORI Biolimus A9-eluting stent

Sponsors

The society of lipid lowering therapy
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Significant stenosi at right coronary artery ostial (within 10mm from ostial) 2) Vessel diameter > 2.5mm 3)

Exclusion criteria

Exclusion criteria: 1) Right coronary artery in which other drug-eluting stent has been implanted. 2) Myocardial infarction within 7 days 3) Chronic total occlusion 4) Female with pregnant 5) Chronic renal failure (SCr.3.0) 6) Patients with malignant diseases

Design outcomes

Primary

MeasureTime frame
MACE (Cardiac death, Q-waveMI, Target lesion revascularization, Target vessel revascularization) at 12 month

Secondary

MeasureTime frame
1) Inhospital MACE 2) Cardiac death at 12 month 3) Myocardial infarction at 12 month 4) Target lesion revascularization at 12 month 5) Target vessel revascularization at 12 month

Countries

Japan

Contacts

Public ContactKenya Nasu

Toyohashi Heart Center Cardiology

yuyatomoya@gmail.com+81532-37-3377

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026